mite allergy disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Persons who meet all of the following criteria will be considered for this study 1) Households with infants (0-6 years old) at the time of application for participation in this study 2) Those who are in an urban area and live in an apartment of 3 bedrooms or less 3) Persons who, of their own free will, have given their consent to participate in this study and to use air purifiers equipped with TPA filters
Exclusion criteria
Exclusion criteria: Persons who violate any of the following criteria will not be included in this study 1) Persons who are participating in other clinical research or clinical trials involving interventions within 3 months prior to obtaining consent 2) Those who are already using an air purifier at home 3) Those who are planning to buy a new futon or bed 4) Those who are using anti-allergy bedding 5) Those who have pets 6) Other persons whose participation in the study is considered inappropriate according to the judgment of the participating physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint will be a comparison of the change in house dust in the intervention group with the difference in house dust in the placebo group as baseline in the rooms of the study subjects. | — |
Secondary
| Measure | Time frame |
|---|---|
| Each of the following items, which can be confirmed from the indoor allergen concentration to be monitored and the results of the questionnaire, will be secondary evaluation items. Difference in the amount of allergens in house dust before and after environmental improvement (installation of air purifiers with TPA filters) Difference in the amount of allergens in house dust on the floor and in bedding Difference in allergen levels according to the questionnaire items | — |
Contacts
International University of Health and Welfare